Spinal translocator protein (TSPO) modulates pain behavior in rats with CFA-induced monoarthritis

Brain Research

Volumn 1286, Issue , 2009, Pages 42-52

  Hernstadt, Hayley ^a,b   Wang, Shuxing ^b   Lim, Grewo ^b   Mao, Jianren ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Arthritis; Inflammation; Inflammatory pain; Pain; Peripheral benzodiazepine receptor; Spinal cord; Translocator protein 18 kDa; TSPO

Indexed keywords

4' CHLORODIAZEPAM; CARRIER PROTEIN; CELL MARKER; FREUND ADJUVANT; GLIAL FIBRILLARY ACIDIC PROTEIN; NEURON SPECIFIC NUCLEAR PROTEIN; PROTEIN ANTIBODY;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MECHANICAL STIMULATION; MICROGLIA; MONARTHRITIS; NERVE CELL; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SPINAL CORD DORSAL HORN; THERMAL STIMULATION; TREATMENT DURATION; UPREGULATION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BEHAVIOR, ANIMAL; BENZODIAZEPINONES; CARRIER PROTEINS; CONVULSANTS; FREUND'S ADJUVANT; FUNCTIONAL LATERALITY; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; SPINAL CORD;

RATTUS;

EID: 68049107195     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.06.043     Document Type: Article

References (83)

1. Anholt R.R., De Souza E.B., Oster-Granite M.L., and Snyder S.H. Peripheral-type benzodiazepine receptors: autoradiographic localization in whole-body sections of neonatal rats. J. Pharmacol. Exp. Ther. 233 (1985) 517-526
2. Anholt R.R., Pedersen P.L., De Souza E.B., and Snyder S.H. The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J. Biol. Chem. 261 (1986) 576-583
3. Anseloni V.C., and Gold M.S. Inflammation-induced shift in the valence of spinal GABA-A receptor-mediated modulation of nociception in the adult rat. J. Pain. 9 (2008) 732-738
4. Basile A.S., and Skolnick P. Subcellular localization of "peripheral-type" binding sites for benzodiazepines in rat brain. J. Neurochem. 46 (1986) 305-308
5. Baulieu E.E. Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog. Horm. Res. 52 (1997) 1-32
6. Beavis A.D. On the inhibition of the mitochondrial inner membrane anion uniporter by cationic amphiphiles and other drugs. J. Biol. Chem. 264 (1989) 1508-1515
7. Besman M.J., Yanagibashi K., Lee T.D., Kawamura M., Hall P.F., and Shively J.E. Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 4897-4901
8. Bessler H., Weizman R., Gavish M., Notti I., and Djaldetti M. Immunomodulatory effect of peripheral benzodiazepine receptor ligands on human mononuclear cells. J. Neuroimmunol. 38 (1992) 19-25
9. Birzniece V., Backstrom T., Johansson I.M., Lindblad C., Lundgren P., Lofgren M., Olsson T., Ragagnin G., Taube M., Turkmen S., Wahlstrom G., Wang M.D., Wihlback A.C., and Zhu D. Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems. Brain Res. Rev. 51 (2006) 212-239
10. Braestrup C., and Squires R.F. Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc. Natl. Acad. Sci. U. S. A. 74 (1977) 3805-3809
11. Bressan E., Farges R.C., Ferrara P., and Tonussi C.R. Comparison of two PBR ligands with classical antiinflammatory drugs in LPS-induced arthritis in rats. Life Sci. 72 (2003) 2591-2601
12. Butler S.H., Godefroy F., Besson J.M., and Weil-Fugazza J. A limited arthritic model for chronic pain studies in the rat. Pain 48 (1992) 73-81
13. Canat X., Carayon P., Bouaboula M., Cahard D., Shire D., Roque C., Le Fur G., and Casellas P. Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells. Life Sci. 52 (1993) 107-118
14. Cao H., and Zhang Y.Q. Spinal glial activation contributes to pathological pain states. Neurosci. Biobehav. Rev. 32 (2008) 972-983
15. Casellas P., Galiegue S., and Basile A.S. Peripheral benzodiazepine receptors and mitochondrial function. Neurochem. Int. 40 (2002) 475-486
16. Catt K.J., Harwood J.P., Clayton R.N., Davies T.F., Chan V., Katikineni M., Nozu K., and Dufau M.L. Regulation of peptide hormone receptors and gonadal steroidogenesis. Recent Prog. Horm. Res. 36 (1980) 557-662
17. Charlet A., Lasbennes F., Darbon P., and Poisbeau P. Fast non-genomic effects of progesterone-derived neurosteroids on nociceptive thresholds and pain symptoms. Pain 139 (2008) 603-609
18. Chen M.K., Baidoo K., Verina T., and Guilarte T.R. Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. Brain 127 (2004) 1379-1392
19. Chen M.K., and Guilarte T.R. Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol. Ther. 118 (2008) 1-17
20. Clark A.K., Gentry C., Bradbury E.J., McMahon S.B., and Malcangio M. Role of spinal microglia in rat models of peripheral nerve injury and inflammation. Eur. J. Pain 11 (2007) 223-230
21. Cornu P., Benavides J., Scatton B., Hauw J.J., and Philippon J. Increase in omega 3 (peripheral-type benzodiazepine) binding site densities in different types of human brain tumours. A quantitative autoradiography study. Acta Neurochir. (Wien). 119 (1992) 146-152
22. Culty M., Li H., Boujrad N., Amri H., Vidic B., Bernassau J.M., Reversat J.L., and Papadopoulos V. In vitro studies on the role of the peripheral-type benzodiazepine receptor in steroidogenesis. J. Steroid Biochem. Mol. Biol. 69 (1999) 123-130
23. DalBo S., Nardi G.M., Ferrara P., Ribeiro-do-Valle R.M., and Farges R.C. Antinociceptive effects of peripheral benzodiazepine receptors. Pharmacology 70 (2004) 188-194
24. Dhir A., and Kulkarni S. Involvement of sigma (sigma1) receptors in modulating the anti-depressant effect of neurosteroids (dehydroepiandrosterone or pregnenolone) in mouse tail-suspension test. J. Psychopharmacol. 22 (2008) 691-696
25. Dubrovsky B. The specificity of stress responses to different nocuous stimuli: neurosteroids and depression. Brain Res. Bull. 51 (2000) 443-455
26. Engel S.R., and Grant K.A. Neurosteroids and behavior. Int. Rev. Neurobiol. 46 (2001) 321-348
27. Eser D., Baghai T.C., Schule C., Nothdurfter C., and Rupprecht R. Neuroactive steroids as endogenous modulators of anxiety. Curr. Pharm. Des. 14 (2008) 3525-3533
28. Farges R.C. Peripheral benzodiazepine receptor ligands and their anti-inflammatory effects. Curr. Med. Chem. - Anti-Inflammatory and Anti-Allergy Agents 2 (2003) 409-416
29. Garnier M., Boujrad N., Oke B.O., Brown A.S., Riond J., Ferrara P., Shoyab M., Suarez-Quian C.A., and Papadopoulos V. Diazepam binding inhibitor is a paracrine/autocrine regulator of Leydig cell proliferation and steroidogenesis: action via peripheral-type benzodiazepine receptor and independent mechanisms. Endocrinology 132 (1993) 444-458
30. Gavish M., Katz Y., Bar-Ami S., and Weizman R. Biochemical, physiological, and pathological aspects of the peripheral benzodiazepine receptor. J. Neurochem. 58 (1992) 1589-1601
31. Gavish M., Bachman I., Shoukrun R., Katz Y., Veenman L., Weisinger G., and Weizman A. Enigma of the peripheral benzodiazepine receptor. Pharmacol. Rev. 51 (1999) 629-650
32. Hardwick M., Fertikh D., Culty M., Li H., Vidic B., and Papadopoulos V. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol. Cancer Res. 59 (1999) 831-842
33. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
34. Hirsch J.D., Beyer C.F., Malkowitz L., Loullis C.C., and Blume A.J. Characterization of ligand binding to mitochondrial benzodiazepine receptors. Mol. Pharmacol. 35 (1989) 164-172
35. Honore P., Rogers S.D., Schwei M.J., Salak-Johnson J.L., Luger N.M., Sabino M.C., Clohisy D.R., and Mantyh P.W. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 98 (2000) 585-598
36. Hua X.Y., Svensson C.I., Matsui T., Fitzsimmons B., Yaksh T.L., and Webb M. Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia. Eur. J. Neurosci. 22 (2005) 2431-2440
37. Jayakumar A.R., Panickar K.S., and Norenberg M.D. Effects on free radical generation by ligands of the peripheral benzodiazepine receptor in cultured neural cells. J. Neurochem. 83 (2002) 1226-1234
38. Ji B., Maeda J., Sawada M., Ono M., Okauchi T., Inaji M., Zhang M.R., Suzuki K., Ando K., Staufenbiel M., Trojanowski J.Q., Lee V.M., Higuchi M., and Suhara T. Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies. J. Neurosci. 28 (2008) 12255-12267
39. Karchewski L.A., Bloechlinger S., and Woolf C.J. Axonal injury-dependent induction of the peripheral benzodiazepine receptor in small-diameter adult rat primary sensory neurons. Eur. J. Neurosci. 20 (2004) 671-683
40. Kletsas D., Li W., Han Z., and Papadopoulos V. Peripheral-type benzodiazepine receptor (PBR) and PBR drug ligands in fibroblast and fibrosarcoma cell proliferation: role of ERK, c-Jun and ligand-activated PBR-independent pathways. Biochem. Pharmacol. 67 (2004) 1927-1932
41. Krueger K.E. Molecular and functional properties of mitochondrial benzodiazepine receptors. Biochim. Biophys. Acta 1241 (1995) 370-453
42. Kuhlmann A.C., and Guilarte T.R. Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity. J. Neurochem. 74 (2000) 1694-1704
43. Lacor P., Gandolfo P., Tonon M.C., Brault E., Dalibert I., Schumacher M., Benavides J., and Ferzaz B. Regulation of the expression of peripheral benzodiazepine receptors and their endogenous ligands during rat sciatic nerve degeneration and regeneration: a role for PBR in neurosteroidogenesis. Brain Res. 815 (1999) 70-80
44. Le Fur G., Guilloux F., Rufat P., Benavides J., Uzan A., Renault C., Dubroeucq M.C., and Gueremy C. Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies. Life Sci. 32 (1983) 1849-1856
45. Ledeboer A., Sloane E.M., Milligan E.D., Frank M.G., Mahony J.H., Maier S.F., and Watkins L.R. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 115 (2005) 71-83
46. Lin Q., Peng Y.B., and Willis W.D. Inhibition of primate spinothalamic tract neurons by spinal glycine and GABA is reduced during central sensitization. J. Neurophysiol. 76 (1996) 1005-1014
47. Lin T., Li K., Zhang F.Y., Zhang Z.K., Light A.R., and Fu K.Y. Dissociation of spinal microglia morphological activation and peripheral inflammation in inflammatory pain models. J. Neuroimmunol. 192 (2007) 40-48
48. Malayev A., Gibbs T.T., and Farb D.H. Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids. Br. J. Pharmacol. 135 (2002) 901-909
49. McEnery M.W., Snowman A.M., Trifiletti R.R., and Snyder S.H. Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 3170-3174
50. Melzack R., and Wall P.D. Textbook of Pain, Vol (1999), Churchill Livingstone, Edinburgh
51. Milligan E.D., and Watkins L.R. Pathological and protective roles of glia in chronic pain. Nat. Rev. Neurosci. 10 (2009) 23-36
52. Mills C., Makwana M., Wallace A., Benn S., Schmidt H., Tegeder I., Costigan M., Brown R.H., Raivich G., and Woolf C.J. Ro5-4864 promotes neonatal motor neuron survival and nerve regeneration in adult rats. European J. Neurosci. 27 (2008) 937-946
53. Mills C.D., Bitler J.L., and Woolf C.J. Role of the peripheral benzodiazepine receptor in sensory neuron regeneration. Mol. Cell Neurosci. 30 (2005) 228-237
54. Mitchell E.A., Herd M.B., Gunn B.G., Lambert J.J., and Belelli D. Neurosteroid modulation of GABAA receptors: molecular determinants and significance in health and disease. Neurochem. Int. 52 (2008) 588-595
55. Moalem G., and Travey D.J. Immune and inflammatory mechanisms in neuropathic pain. Brain Res. Rev. 51 (2006) 240-264
56. Mukherjee S., and Das S.K. Subcellular distribution of "peripheral type" binding sites for [3H]Ro5-4864 in guinea pig lung. Localization to the mitochondrial inner membrane. J. Biol. Chem. 264 (1989) 16713-16718
57. Nimmerjahn A., Kirchhoff F., and Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308 (2005) 1314-1318
58. Olson J.M., Ciliax B.J., Mancini W.R., and Young A.B. Presence of peripheral-type benzodiazepine binding sites on human erythrocyte membranes. Eur. J. Pharmacol. 152 (1988) 47-53
59. Papadopoulos V. Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocr. Rev. 14 (1993) 222-240
60. Papadopoulos V., Amri H., Boujrad N., Cascio C., Culty M., Garnier M., Hardwick M., Li H., Vidic B., Brown A.S., Reversa J.L., Bernassau J.M., and Drieu K. Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis. Steroids 62 (1997) 21-28
61. Papadopoulos V., Baraldi M., Guilarte T.R., Knudsen T.B., Lacapere J.J., Lindemann P., Norenberg M.D., Nutt D., Weizman A., Zhang M.R., and Gavish M. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends. Pharmacol. Sci. 27 (2006) 402-409
62. Papadopoulos V., Lecanu L., and Brown R.C. Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience 138 (2006) 749-756
63. Pathirathna S., Todorovic S.M., Covey D.F., and Jevtovic-Todorovic V. 5alpha-reduced neuroactive steroids alleviate thermal and mechanical hyperalgesia in rats with neuropathic pain. Pain 117 (2005) 326-339
64. Poisbeau P., Patte-Mensah C., Keller A.F., Barrot M., Breton J.D., Luis-Delgado O.E., Freund-Mercier M.J., Mensah-Nyagan A.G., and Schlichter R. Inflammatory pain upregulates spinal inhibition via endogenous neurosteroid production. J. Neurosci. 25 (2005) 11768-11776
65. Raghavendra V., Tanga F.Y., and DeLeo J.A. Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur. J. Neurosci. 20 (2004) 467-473
66. Romeo E., Auta J., Kozikowski A.P., Ma D., Papadopoulos V., Puia G., Costa E., and Guidotti A. 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR). J. Pharmacol. Exp. Ther. 262 (1992) 971-978
67. Schlichter R., Keller A.F., De Roo M., Breton J.D., Inquimbert P., and Poisbeau P. Fast nongenomic effects of steroids on synaptic transmission and role of endogenous neurosteroids in spinal pain pathways. J. Mol. Neurosci. 28 (2006) 33-51
68. Schoemaker H., Morelli M., Deshmukh P., and Yamamura H.I. [3H]Ro5-4864 benzodiazepine binding in the kainate lesioned striatum and Huntington's diseased basal ganglia. Brain Res. 248 (1982) 396-401
69. Snyder S.H., Verma A., and Trifiletti R.R. The peripheral-type benzodiazepine receptor: a protein of mitochondrial outer membranes utilizing porphyrins as endogenous ligands. FASEB J. 1 (1987) 282-288
70. Sun S., Cao H., Han M., Li T.T., Pan H.L., Zhao Z.Q., and Zhang Y.Q. New evidence for the involvement of spinal fractalkine receptor in pain facilitation and spinal glial activation in rat model of monoarthritis. Pain 129 (2007) 64-75
71. Torres S.R., Nardi G.M., Ferrara P., Ribeiro-do-Valle R.M., and Farges R.C. Potential role of peripheral benzodiazepine receptors in inflammatory responses. Eur. J. Pharmacol. 385 (1999) R1-R2
72. Torres S.R., Frode T.S., Nardi G.M., Vita N., Reeb R., Ferrara P., Ribeiro-do-Valle R.M., and Farges R.C. Anti-inflammatory effects of peripheral benzodiazepine receptor ligands in two mouse models of inflammation. Eur. J. Pharmacol. 408 (2000) 199-211
73. Veenman L., Papadopoulos V., and Gavish M. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Curr. Pharm. Des. 13 (2007) 2385-2405
74. Veenman L., Shandalov Y., and Gavish M. VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis. J. Bioenerg. Biomembr. 40 (2008) 199-205
75. Verge G.M., Milligan E.D., Maier S.F., Watkins L.R., Naeve G.S., and Foster A.C. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur. J. Neurosci. 20 (2004) 1150-1160
76. Verma A., Nye J.S., and Snyder S.H. Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 2256-2260
77. Vowinckel E., Reutens D., Becher B., Verge G., Evans A., Owens T., and Antel J.P. PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J. Neurosci. Res. 50 (1997) 345-353
78. Watkins L.R., Milligan E.D., and Maier S.F. Glial activation: a driving force for pathological pain. Trends Neurosci. 24 (2001) 450-455
79. Watkins L.R., and Maier S.F. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol. Rev. 82 (2002) 981-1011
80. Weizman R., and Gavish M. Molecular cellular and behavioral aspects of peripheral-type benzodiazepine receptors. Clin. Neuropharmacol. 16 (1993) 401-417
81. Wilms H., Claasen J., Rohl C., Sievers J., Deuschl G., and Lucius R. Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro. Neurobiol. Dis. 14 (2003) 417-424
82. Xiao H.S., Huang Q.H., Zhang F.X., Bao L., Lu Y.J., Guo C., Yang L., Huang W.J., Fu G., Xu S.H., Cheng X.P., Yan Q., Zhu Z.D., Zhang X., Chen Z., and Han Z.G. Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 8360-8365
83. Yaksh T.L., and Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17 (1976) 1031-1036